Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer. [electronic resource]
Producer: 20200511Description: 2241-2253 p. digitalISSN:- 1557-3265
- Animals
- Biomarkers
- Cytotoxicity, Immunologic
- Disease Models, Animal
- Female
- Flow Cytometry
- Humans
- Immunohistochemistry
- Immunophenotyping
- Immunotherapy, Adoptive -- methods
- Mice
- Mice, Knockout
- Neoplasms -- immunology
- T-Lymphocyte Subsets -- immunology
- Transplantation, Homologous
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.